Plicera News
Most Popular Plicera Story
Amicus gets a drubbing after Gaucher drug disappoints
Shares of Amicus Therapeutics (FOLD) plunged 33 percent this morning after it announced that its therapy for Gaucher disease appeared to work in only one out of the 18 patients who completed a Read more...
Latest Headlines
- October 5, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
